According to SP Tulsian of sptulsian.com, Lupin may touch Rs 885-890. “The company received the USFDA approval for launch of the generic version of the Sanofi‘s Ambien, which is for curing of insomnia and it has USD 400 million markets,†he adds.
first published: Sep 17, 2013 12:05 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
